CD44 and neoplasm: Considering that cancer stem cells (CSCs) are a group of quiescent cells within the tumour bulk that are believed to be responsible for tumorigenesis, resistance, relapse, and poor clinical outcomes, we evaluated the expression of miR-1307-5p in the CD44+ subpopulation derived from the OECM1 cell line [12].